GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rakovina Therapeutics Inc (TSXV:RKV) » Definitions » Future Policy Benefits

Rakovina Therapeutics (TSXV:RKV) Future Policy Benefits


View and export this data going back to 2021. Start your Free Trial

What is Rakovina Therapeutics Future Policy Benefits?

Future Policy Benefits only applies to insurance companies.


Rakovina Therapeutics Business Description

Traded in Other Exchanges
Address
105 1008 Beach Avenue, Vancouver, BC, CAN, V6E 1T7
Rakovina Therapeutics Inc is a biopharmaceutical research company focused on the development of cancer treatments. Its work is based on technologies for targeting the DNA-damage response powered by Artificial Intelligence (AI) using proprietary, generative AI platforms. By using AI, it can review and optimize drug candidates at a much greater pace than ever before. The company has established a pipeline of distinctive DNA-damage response inhibitors with the goal of advancing one or more drug candidates into human clinical trials in collaboration with pharmaceutical partners.
Executives
Jeffrey Bacha Senior Officer
Alfredo De Lucrezia Director, Senior Officer
Michael Liggett Director
Mads Daugaard Senior Officer
David Hyman Senior Officer
John Michael Langlands Senior Officer